Optimi Health Announces CAD $3,000,000 Senior Debt Financing
10. August 2023 07:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
01. August 2023 07:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
Optimi Health Aims to Expand its Shareholder Base
06. April 2021 09:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom...